Resmed Is Still A Strong Profit Grower With New Product Launches Expected Soon
LN Investors • Wed, Aug. 20
- Sales up outside of North and Latin America.
- Some US sales weakness may be due to order delays from anticipated new products expected out soon.
- Resmed maintains its strong track record for profits and net gearing is -34.4% due to strong cash position more than 3 times long-term debt.